Here are six takeaways from the filing:
1. Invuity filed for an IPO to raise $69 million.
2. The company plans to use the proceeds to expand sales, marketing and research and development to fund working capital and general purposes.
3. The price range and number of shares to be sold in the IPO has not yet been determined.
4. Invuity develops surgical devices that utilize advanced photonics. The devices aim to provide surgeons with direct illumination and improved visualization during minimally invasive and minimal access surgeries.
5. Invuity also recently completed a $20 million equity financing round. The financing round was led by Wellington Management Company.
6. In all, Invuity has raised $96.7 million from private placements of convertible preferred securities.
More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics’ 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
